Sorrento Therapeutics Inc Asset Turnover Ratio (SRNEQ), as of second quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Sorrento Therapeutics Inc   (SRNEQ)
 

Sorrento Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Sorrento Therapeutics Inc asset turnover ratio, the ability of Sorrento Therapeutics Inc 's assets to generate revenue in the second quarter 2023, increased sequentially to 0.15 in the second quarter (Jun 30 2023), SRNEQ's balance sheet remain strong.

Within sector 43 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the II Quarter 2023, to 3523, from total ranking in the first quarter 2023 at 3623.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SRNEQ Asset Turnover Ratio (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Asset Change -26.23 % -51.13 % -36.47 % -21.65 % -26.42 %
Y / Y Revenue Change 31.1 % -11.61 % 19.26 % 44.25 % -15.17 %
Asset Turnover Ratio (TTM) 0.15 0.13 0.11 0.1 0.08
SRNEQ's Total Ranking # 3523 # 3623 # 4191 # 3711 # 3808
Seq. Asset Change 6.92 % -2.77 % -27 % -2.79 % -29.17 %
Seq. Revenue Change -7.54 % 4.21 % -10.38 % 51.82 % -37.66 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 44
Healthcare Sector # 521
Overall Market # 3523

Asset Turnover Ratio Statistics
High Average Low
0.38 0.08 0.01
(Dec 31 2017)   (Dec 31 2013)




SRNEQ Company Profile • Back to SRNEQ Efficiency Comparisons • Compare SRNEQ Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2023 Assets at quarter ending Jun 30 2023
Axsome Therapeutics Inc   0.44 $ 182.493  Millions$ 417.813  Millions
Moderna Inc   0.44 $ 10,654.000  Millions$ 24,480.750  Millions
Hologic Inc  0.43 $ 4,038.100  Millions$ 9,287.025  Millions
Ardelyx inc   0.43 $ 82.866  Millions$ 190.740  Millions
Avita Medical Inc   0.43 $ 40.850  Millions$ 94.287  Millions
Artivion Inc   0.43 $ 328.549  Millions$ 760.116  Millions
Novocure Limited  0.43 $ 507.660  Millions$ 1,174.805  Millions
Assertio Holdings inc   0.43 $ 168.022  Millions$ 389.178  Millions
Regeneron Pharmaceuticals Inc   0.43 $ 12,670.800  Millions$ 29,402.425  Millions
Nuwellis Inc   0.43 $ 8.305  Millions$ 19.286  Millions
Akumin Inc   0.43 $ 743.672  Millions$ 1,733.192  Millions
Halozyme Therapeutics Inc   0.43 $ 773.653  Millions$ 1,803.985  Millions
Nanostring Technologies Inc   0.43 $ 143.925  Millions$ 336.604  Millions
Perrigo Company Plc  0.42 $ 4,628.900  Millions$ 10,903.600  Millions
Teleflex Incorporated  0.42 $ 2,898.539  Millions$ 6,874.949  Millions
Ontrak Inc   0.42 $ 10.842  Millions$ 25.968  Millions
Utah Medical Products Inc  0.41 $ 51.789  Millions$ 125.133  Millions
Xeris Biopharma Holdings Inc   0.41 $ 134.073  Millions$ 324.419  Millions
Pacira Biosciences inc   0.41 $ 669.229  Millions$ 1,620.341  Millions
Clearpoint Neuro Inc   0.41 $ 21.703  Millions$ 52.779  Millions
Boston Scientific Corporation  0.41 $ 13,402.000  Millions$ 32,727.250  Millions
Uphealth Inc   0.41 $ 155.855  Millions$ 380.604  Millions
Abbvie Inc   0.41 $ 56,023.000  Millions$ 137,510.250  Millions
Marker Therapeutics inc   0.41 $ 12.756  Millions$ 31.358  Millions
Bioadaptives Inc   0.41 $ 0.013  Millions$ 0.032  Millions
Integra Lifesciences Holdings Corp  0.41 $ 1,545.326  Millions$ 3,804.193  Millions
Genedx Holdings Corp   0.40 $ 235.480  Millions$ 585.400  Millions
Biogen Inc   0.40 $ 9,971.500  Millions$ 24,790.875  Millions
Surgery Partners Inc   0.40 $ 2,661.500  Millions$ 6,620.625  Millions
Horizon Therapeutics Public Limited Company  0.40 $ 3,643.448  Millions$ 9,108.667  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.